Know Cancer

or
forgot password

Collection of Outcomes Data for Pregnant Patients With Cancer


N/A
N/A
N/A
Open (Enrolling)
Female
Solid Tumors, Pregnancy

Thank you

Trial Information

Collection of Outcomes Data for Pregnant Patients With Cancer


If you agree to take part in this study, information about the type of cancer, the type of
treatment you have had or are having, and details about your pregnancy will be collected for
the database. Data will be collected from patients seen at MD Anderson since September
2003 until data has been collected for 500 cases. This information will serve as a basis for
future studies about pregnant women with cancer. You will receive no special tests or
treatment at MD Anderson as a result of this study.

Progress notes and ultrasound reports about your pregnancy will be requested from Maternal
Fetal Medicine and/or from your personal obstetrician. This information will be entered into
the database and also included in your medical record. If the information is not consistent
in the record, we may contact you to clarify the information. You will remain on study until
your pregnancy and/or any treatment you are receiving are completed.

Periodically the database will be updated to include information about patient survival.
This information is usually found in the medical record however it may be necessary to
contact you directly.

This is an investigational study. About 500 patients will take part in this study. All
will be enrolled at MD Anderson.


Inclusion Criteria:



1. All pregnant patients with cancer and patients known to have been pregnant with a
diagnosis of cancer are eligible, regardless of their diagnosis or treatment plan.

2. Patients may receive prenatal care from any obstetrician, but a consult with a
Maternal Fetal Medicine physician is encouraged.

Exclusion Criteria:

N/A

Type of Study:

Observational

Study Design:

Observational Model: Case-Only

Outcome Measure:

Research database of information on patients who are or were pregnant while diagnosed with cancer.

Outcome Time Frame:

14 Years

Safety Issue:

No

Principal Investigator

Andrea Milbourne, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

2005-0518

NCT ID:

NCT00507572

Start Date:

December 2005

Completion Date:

Related Keywords:

  • Solid Tumors
  • Pregnancy
  • Solid Tumors
  • Pregnancy
  • Data Collection

Name

Location

UT MD Anderson Cancer Center Houston, Texas  77030